quarterly actually came in not bad given its early infancy. $5million cash at hand, $8mill turnover higher than expectations once again given its early stages and given CanPharma acquisition as yet wouldnt have any impact on the bottom line,the upside and growth parameters once up and running should prove to outpace forecasted revenues. Saw nothing negative in the quarterly and like somebody else stated, this was always going to be a 12 month hold at minimum to see this gain traction. Gaurantee it wont be at these low levels once escrow allocations come into play
HHI Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held
